Listen to the latest episode of the ASBMB's science policy podcast with Public Affairs Director Benjamin Corb.
Find all of the Pipettes & Politics episodes on Soundcloud, or subscribe wherever you get your podcasts.
Funding agency guidance and resourcesSee our list of guidance and resources from the NSF, NIH, DOE and others.
Remote study sections
The coronavirus pandemic has forced federal agencies to move study sections to virtual settings, allowing reviews to continue while also allowing reviewers to follow federal guidance restricting travel and personal interactions.
In an effort to measure and understand the impact that remote peer review might have on science (positive or negative) the ASBMB encourages you to take a moment and share your thoughts and experiences regarding online study sections.
JBC's coronavirus virtual issue presents a retrospective collection of content on coronavirus entry, proteases and host interactions to help researchers build more quickly toward therapeutic endpoints against SARS-CoV-2 and future strains.
As scientists look for ways to help fight the new coronavirus, a group of grad students and postdocs create a database to connect volunteers with local health departments.
Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.
The pipetting robots are already in place, but that doesn’t make it easy. Here's how academic laboratories are quickly pivoting to provide testing for the coronavirus.
The eye-catching spikes sticking out from the surface of SARS-CoV-2 may inspire new ways to prevent or treat COVID-19 infections.
Our science writers selected 10 examples of solid scicomm about the novel coronavirus.
In a department that feels almost deserted, basic scientists join the COVID-19 effort.
Clinical trials around the world are testing remdesivir, a nucleotide analog, for possible effects against the novel coronavirus. We asked some experts what makes the molecule interesting.
The COVID-19 pandemic has many people asking, "What can I do to help?" Here, we round up a list of actions that research scientists can take.
We asked ASBMB members how the pandemic is affecting them personally and professionally. Here are their dispatches.
As hospitalized COVID-19 patients undergo experimental therapy, research published in the Journal of Biological Chemistry explains how the drug, remdesivir, stops replication in coronaviruses.
As new cases of the novel coronavirus appear daily, researchers in China have found that two drugs, chloroquine and remdesivir, can inhibit its replication in cell culture.